Sonnet BioTherapeutics Holdings Inc. [NASDAQ:SONN] prices rallied 6.45% on Thursday.
With a current price of $2.97, SONN is active in the Biotechnology industry and it looks to be on-track for a five-day run of 11.65%.
In addition, SONN’s high over the last year is $54.60 and the low is $2.23. Over the last two 52 weeks, the company is trading -85.62%, while the S&P 500 is trading 0.79%.
The Price is right
Holding a Market Cap of $39.20 million, Sonnet BioTherapeutics Holdings Inc. has seen a trading range over the last year of $2.23-$54.60.
For the last five days, SONN is up from its last closing price. The average shares trading hands each day is 4.45M.
Using a Force Index Indicator is a good way to look at how strong actual buying and selling pressure is for SONN. When we apply the Elder Force Index to Sonnet BioTherapeutics Holdings Inc., we are seeing an Elder Force Indicator number of 437212.44.
Looking at popular technical indicators, the company’s 5-day moving average is 2.80 compared to the 50-day moving average of 10.43%. So, traders might want to tread carefully if they are going to bid.
The Relative Strength Index or RSI is an indicator ranging between 0 and 100 that traders use to determine if a stock is “overbought” or “oversold.” A strong uptrend tending to reach into the “overbought” status is above 70, while a downward trend will stay around the 30 mark. SONN currently holds a 9-day RSI of 73.61%, while 100-day RSI stands at 44.63%.
Another indicator we believe is worth keeping tabs on is the Moving Average Convergence Divergence or MACD. Similar to the concept of the Force Index — on the basis of price momentum — the MACD gives traders a tool to measure the turning point of a stock even during rapid fluctuations in price. Buy and sell signals are determined by a stock’s relation to the zero line, so if a stock is above a zero line for many weeks it might be a “buy.” On the other hand, if a stock is below the zero line consistently, it might be one to stay away from. Also, if the MACD line reaches a peak and dips, its momentum may be waning. SONN’s 9-day MACD is 0.14 and the company’s 100-day MACD stands at -0.41.
Another area that is important to analyze is insider moves and majority shareholders. While this is not always an error-free way to tell what the future holds for a stock, you can maybe gather important information from reading the tea leaves about who is buying and selling.
The major holders for this stock are 0.77% by insiders and 0.52% by institutions. Regarding institutional holdings, Blackrock Inc. owns 1.77%, while the second top holder, Tower Research Capital LLC (TRC), currently owns 0.03%.
Overall, the recommended rating for SONN is Moderate Buy. Currently, the company has 0 analysts watching the stock, and the average quarterly earnings estimate is 0. Quarterly revenue estimates are averaging 9.65M with the high estimate reaching 11.48M and the low at 11.48M.